Global Nicotinamide Mononucleotide (NMN) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Nicotinamide Mononucleotide (NMN) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 91

Published Date: 05 Jul 2022

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Nicotinamide Mononucleotide (NMN) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nicotinamide Mononucleotide (NMN) market size is estimated to be worth US$ 264.2 million in 2021 and is forecast to a readjusted size of USD 911.8 million by 2028 with a CAGR of 19.4% during forecast period 2022-2028. Health Care Products accounting for % of the Nicotinamide Mononucleotide (NMN) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Content Greater than or Equal to 98% segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, and Maac10 Formulas, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Nicotinamide Mononucleotide (NMN) market is split by Purity and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Purity and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Purity, covers
Content Greater than or Equal to 98%
Content Less than 98%

Market segment by Application can be divided into
Health Care Products
Cosmetics
Others

The key market players for global Nicotinamide Mononucleotide (NMN) market are listed below:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinamide Mononucleotide (NMN) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of Nicotinamide Mononucleotide (NMN) from 2019 to 2022.
Chapter 3, the Nicotinamide Mononucleotide (NMN) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Purity and application, with sales market share and growth rate by purity, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nicotinamide Mononucleotide (NMN) market forecast, by regions, purity and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nicotinamide Mononucleotide (NMN).
Chapter 13, 14, and 15, to describe Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Nicotinamide Mononucleotide (NMN) Introduction
1.2 Market Analysis by Purity
1.2.1 Overview: Global Nicotinamide Mononucleotide (NMN) Revenue by Purity: 2017 Versus 2021 Versus 2028
1.2.2 Content Greater than or Equal to 98%
1.2.3 Content Less than 98%
1.3 Market Analysis by Application
1.3.1 Overview: Global Nicotinamide Mononucleotide (NMN) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.4.1 Global Nicotinamide Mononucleotide (NMN) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nicotinamide Mononucleotide (NMN) Sales in Volume (2017-2028)
1.4.3 Global Nicotinamide Mononucleotide (NMN) Price (2017-2028)
1.5 Global Nicotinamide Mononucleotide (NMN) Production Capacity Analysis
1.5.1 Global Nicotinamide Mononucleotide (NMN) Total Production Capacity (2017-2028)
1.5.2 Global Nicotinamide Mononucleotide (NMN) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nicotinamide Mononucleotide (NMN) Market Drivers
1.6.2 Nicotinamide Mononucleotide (NMN) Market Restraints
1.6.3 Nicotinamide Mononucleotide (NMN) Trends Analysis

2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Nicotinamide Mononucleotide (NMN) Breakdown Data by Manufacturer
3.1 Global Nicotinamide Mononucleotide (NMN) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nicotinamide Mononucleotide (NMN)
3.4 Market Concentration Rate
3.4.1 Top 3 Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2021
3.4.2 Top 6 Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2021
3.5 Global Nicotinamide Mononucleotide (NMN) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nicotinamide Mononucleotide (NMN) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2017-2028)
4.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028)
4.2 North America Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.3 Europe Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.4 Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.5 South America Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.6 Middle East and Africa Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)

5 Market Segment by Purity
5.1 Global Nicotinamide Mononucleotide (NMN) Sales in Volume by Purity (2017-2028)
5.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Purity (2017-2028)
5.3 Global Nicotinamide Mononucleotide (NMN) Price by Purity (2017-2028)

6 Market Segment by Application
6.1 Global Nicotinamide Mononucleotide (NMN) Sales in Volume by Application (2017-2028)
6.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028)
6.3 Global Nicotinamide Mononucleotide (NMN) Price by Application (2017-2028)

7 North America by Country, by Purity, and by Application
7.1 North America Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
7.2 North America Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
7.3 North America Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
7.3.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Purity, and by Application
8.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
8.2 Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
8.3 Europe Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
8.3.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Purity, and by Application
9.1 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
9.2 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
9.3 Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Purity, and by Application
10.1 South America Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
10.2 South America Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
10.3 South America Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
10.3.2 South America Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Purity, and by Application
11.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
11.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
11.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Nicotinamide Mononucleotide (NMN) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nicotinamide Mononucleotide (NMN)
12.3 Nicotinamide Mononucleotide (NMN) Production Process
12.4 Nicotinamide Mononucleotide (NMN) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nicotinamide Mononucleotide (NMN) Typical Distributors
13.3 Nicotinamide Mononucleotide (NMN) Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Nicotinamide Mononucleotide (NMN) Revenue by Purity, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nicotinamide Mononucleotide (NMN) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor Nicotinamide Mononucleotide (NMN) Product and Services
Table 6. GeneHarbor Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 8. Herbalmax Major Business
Table 9. Herbalmax Nicotinamide Mononucleotide (NMN) Product and Services
Table 10. Herbalmax Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 12. Genex Formulas Major Business
Table 13. Genex Formulas Nicotinamide Mononucleotide (NMN) Product and Services
Table 14. Genex Formulas Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Shinkowa Pharmaceutical Major Business
Table 17. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product and Services
Table 18. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 20. Maac10 Formulas Major Business
Table 21. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product and Services
Table 22. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. EffePharm Basic Information, Manufacturing Base and Competitors
Table 24. EffePharm Major Business
Table 25. EffePharm Nicotinamide Mononucleotide (NMN) Product and Services
Table 26. EffePharm Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bontac Basic Information, Manufacturing Base and Competitors
Table 28. Bontac Major Business
Table 29. Bontac Nicotinamide Mononucleotide (NMN) Product and Services
Table 30. Bontac Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CELFULL Basic Information, Manufacturing Base and Competitors
Table 32. CELFULL Major Business
Table 33. CELFULL Nicotinamide Mononucleotide (NMN) Product and Services
Table 34. CELFULL Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 36. Kingdomway Major Business
Table 37. Kingdomway Nicotinamide Mononucleotide (NMN) Product and Services
Table 38. Kingdomway Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Nicotinamide Mononucleotide (NMN) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 40. Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Nicotinamide Mononucleotide (NMN) Production Capacity by Company, (Kg): 2020 VS 2021
Table 43. Head Office and Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
Table 44. Nicotinamide Mononucleotide (NMN) New Entrant and Capacity Expansion Plans
Table 45. Nicotinamide Mononucleotide (NMN) Mergers & Acquisitions in the Past Five Years
Table 46. Global Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 47. Global Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
Table 48. Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 51. Global Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 52. Global Nicotinamide Mononucleotide (NMN) Revenue by Purity (2017-2022) & (USD Million)
Table 53. Global Nicotinamide Mononucleotide (NMN) Revenue by Purity (2023-2028) & (USD Million)
Table 54. Global Nicotinamide Mononucleotide (NMN) Price by Purity (2017-2022) & (USD/Kg)
Table 55. Global Nicotinamide Mononucleotide (NMN) Price by Purity (2023-2028) & (USD/Kg)
Table 56. Global Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 57. Global Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 58. Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) & (USD/Kg)
Table 61. Global Nicotinamide Mononucleotide (NMN) Price by Application (2023-2028) & (USD/Kg)
Table 62. North America Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 63. North America Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
Table 64. North America Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 67. North America Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 68. North America Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 69. North America Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 70. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 71. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
Table 72. Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 75. Europe Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 76. Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 77. Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 78. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 79. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
Table 80. Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 83. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 84. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 85. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 86. South America Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 87. South America Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
Table 88. South America Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 91. South America Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 92. South America Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 93. South America Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 94. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 95. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
Table 96. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 99. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 100. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 101. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 102. Nicotinamide Mononucleotide (NMN) Raw Material
Table 103. Key Manufacturers of Nicotinamide Mononucleotide (NMN) Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Nicotinamide Mononucleotide (NMN) Typical Distributors
Table 107. Nicotinamide Mononucleotide (NMN) Typical Customers
List of Figures
Figure 1. Nicotinamide Mononucleotide (NMN) Picture
Figure 2. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Purity in 2021
Figure 3. Content Greater than or Equal to 98%
Figure 4. Content Less than 98%
Figure 5. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2021
Figure 6. Health Care Products
Figure 7. Cosmetics
Figure 8. Others
Figure 9. Global Nicotinamide Mononucleotide (NMN) Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 10. Global Nicotinamide Mononucleotide (NMN) Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Nicotinamide Mononucleotide (NMN) Sales (2017-2028) & (Kg)
Figure 12. Global Nicotinamide Mononucleotide (NMN) Price (2017-2028) & (USD/Kg)
Figure 13. Global Nicotinamide Mononucleotide (NMN) Production Capacity (2017-2028) & (Kg)
Figure 14. Global Nicotinamide Mononucleotide (NMN) Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Nicotinamide Mononucleotide (NMN) Market Drivers
Figure 16. Nicotinamide Mononucleotide (NMN) Market Restraints
Figure 17. Nicotinamide Mononucleotide (NMN) Market Trends
Figure 18. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturer in 2021
Figure 19. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturer in 2021
Figure 20. Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 24. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2028)
Figure 25. North America Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 26. Europe Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 28. South America Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 30. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 31. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Purity (2017-2028)
Figure 32. Global Nicotinamide Mononucleotide (NMN) Price by Purity (2017-2028) & (USD/Kg)
Figure 33. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 34. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
Figure 35. Global Nicotinamide Mononucleotide (NMN) Price by Application (2017-2028) & (USD/Kg)
Figure 36. North America Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 37. North America Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 38. North America Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2028)
Figure 39. North America Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2028)
Figure 40. United States Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 44. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 45. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2028)
Figure 46. Europe Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2028)
Figure 47. Germany Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2028)
Figure 56. China Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 63. South America Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 64. South America Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2028)
Figure 65. South America Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 69. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) in 2021
Figure 77. Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
Figure 78. Nicotinamide Mononucleotide (NMN) Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Nicotinamide Mononucleotide (NMN) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Nicotinamide Mononucleotide (NMN) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 91

Published Date: 05 Jul 2022

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Nicotinamide Mononucleotide (NMN) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nicotinamide Mononucleotide (NMN) market size is estimated to be worth US$ 264.2 million in 2021 and is forecast to a readjusted size of USD 911.8 million by 2028 with a CAGR of 19.4% during forecast period 2022-2028. Health Care Products accounting for % of the Nicotinamide Mononucleotide (NMN) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Content Greater than or Equal to 98% segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, and Maac10 Formulas, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Nicotinamide Mononucleotide (NMN) market is split by Purity and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Purity and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Purity, covers
Content Greater than or Equal to 98%
Content Less than 98%

Market segment by Application can be divided into
Health Care Products
Cosmetics
Others

The key market players for global Nicotinamide Mononucleotide (NMN) market are listed below:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinamide Mononucleotide (NMN) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of Nicotinamide Mononucleotide (NMN) from 2019 to 2022.
Chapter 3, the Nicotinamide Mononucleotide (NMN) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Purity and application, with sales market share and growth rate by purity, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nicotinamide Mononucleotide (NMN) market forecast, by regions, purity and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nicotinamide Mononucleotide (NMN).
Chapter 13, 14, and 15, to describe Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Nicotinamide Mononucleotide (NMN) Introduction
1.2 Market Analysis by Purity
1.2.1 Overview: Global Nicotinamide Mononucleotide (NMN) Revenue by Purity: 2017 Versus 2021 Versus 2028
1.2.2 Content Greater than or Equal to 98%
1.2.3 Content Less than 98%
1.3 Market Analysis by Application
1.3.1 Overview: Global Nicotinamide Mononucleotide (NMN) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.4.1 Global Nicotinamide Mononucleotide (NMN) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nicotinamide Mononucleotide (NMN) Sales in Volume (2017-2028)
1.4.3 Global Nicotinamide Mononucleotide (NMN) Price (2017-2028)
1.5 Global Nicotinamide Mononucleotide (NMN) Production Capacity Analysis
1.5.1 Global Nicotinamide Mononucleotide (NMN) Total Production Capacity (2017-2028)
1.5.2 Global Nicotinamide Mononucleotide (NMN) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nicotinamide Mononucleotide (NMN) Market Drivers
1.6.2 Nicotinamide Mononucleotide (NMN) Market Restraints
1.6.3 Nicotinamide Mononucleotide (NMN) Trends Analysis

2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Nicotinamide Mononucleotide (NMN) Breakdown Data by Manufacturer
3.1 Global Nicotinamide Mononucleotide (NMN) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nicotinamide Mononucleotide (NMN)
3.4 Market Concentration Rate
3.4.1 Top 3 Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2021
3.4.2 Top 6 Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2021
3.5 Global Nicotinamide Mononucleotide (NMN) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nicotinamide Mononucleotide (NMN) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 Market Analysis by Region
4.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2017-2028)
4.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028)
4.2 North America Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.3 Europe Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.4 Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.5 South America Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)
4.6 Middle East and Africa Nicotinamide Mononucleotide (NMN) Revenue (2017-2028)

5 Market Segment by Purity
5.1 Global Nicotinamide Mononucleotide (NMN) Sales in Volume by Purity (2017-2028)
5.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Purity (2017-2028)
5.3 Global Nicotinamide Mononucleotide (NMN) Price by Purity (2017-2028)

6 Market Segment by Application
6.1 Global Nicotinamide Mononucleotide (NMN) Sales in Volume by Application (2017-2028)
6.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028)
6.3 Global Nicotinamide Mononucleotide (NMN) Price by Application (2017-2028)

7 North America by Country, by Purity, and by Application
7.1 North America Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
7.2 North America Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
7.3 North America Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
7.3.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Purity, and by Application
8.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
8.2 Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
8.3 Europe Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
8.3.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Purity, and by Application
9.1 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
9.2 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
9.3 Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Purity, and by Application
10.1 South America Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
10.2 South America Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
10.3 South America Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
10.3.2 South America Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Purity, and by Application
11.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2028)
11.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
11.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
12.1 Raw Material of Nicotinamide Mononucleotide (NMN) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nicotinamide Mononucleotide (NMN)
12.3 Nicotinamide Mononucleotide (NMN) Production Process
12.4 Nicotinamide Mononucleotide (NMN) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nicotinamide Mononucleotide (NMN) Typical Distributors
13.3 Nicotinamide Mononucleotide (NMN) Typical Customers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Nicotinamide Mononucleotide (NMN) Revenue by Purity, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nicotinamide Mononucleotide (NMN) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor Nicotinamide Mononucleotide (NMN) Product and Services
Table 6. GeneHarbor Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 8. Herbalmax Major Business
Table 9. Herbalmax Nicotinamide Mononucleotide (NMN) Product and Services
Table 10. Herbalmax Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 12. Genex Formulas Major Business
Table 13. Genex Formulas Nicotinamide Mononucleotide (NMN) Product and Services
Table 14. Genex Formulas Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Shinkowa Pharmaceutical Major Business
Table 17. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product and Services
Table 18. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 20. Maac10 Formulas Major Business
Table 21. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product and Services
Table 22. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. EffePharm Basic Information, Manufacturing Base and Competitors
Table 24. EffePharm Major Business
Table 25. EffePharm Nicotinamide Mononucleotide (NMN) Product and Services
Table 26. EffePharm Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bontac Basic Information, Manufacturing Base and Competitors
Table 28. Bontac Major Business
Table 29. Bontac Nicotinamide Mononucleotide (NMN) Product and Services
Table 30. Bontac Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CELFULL Basic Information, Manufacturing Base and Competitors
Table 32. CELFULL Major Business
Table 33. CELFULL Nicotinamide Mononucleotide (NMN) Product and Services
Table 34. CELFULL Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 36. Kingdomway Major Business
Table 37. Kingdomway Nicotinamide Mononucleotide (NMN) Product and Services
Table 38. Kingdomway Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Nicotinamide Mononucleotide (NMN) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 40. Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Nicotinamide Mononucleotide (NMN) Production Capacity by Company, (Kg): 2020 VS 2021
Table 43. Head Office and Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
Table 44. Nicotinamide Mononucleotide (NMN) New Entrant and Capacity Expansion Plans
Table 45. Nicotinamide Mononucleotide (NMN) Mergers & Acquisitions in the Past Five Years
Table 46. Global Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 47. Global Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
Table 48. Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 51. Global Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 52. Global Nicotinamide Mononucleotide (NMN) Revenue by Purity (2017-2022) & (USD Million)
Table 53. Global Nicotinamide Mononucleotide (NMN) Revenue by Purity (2023-2028) & (USD Million)
Table 54. Global Nicotinamide Mononucleotide (NMN) Price by Purity (2017-2022) & (USD/Kg)
Table 55. Global Nicotinamide Mononucleotide (NMN) Price by Purity (2023-2028) & (USD/Kg)
Table 56. Global Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 57. Global Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 58. Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) & (USD/Kg)
Table 61. Global Nicotinamide Mononucleotide (NMN) Price by Application (2023-2028) & (USD/Kg)
Table 62. North America Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 63. North America Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
Table 64. North America Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 67. North America Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 68. North America Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 69. North America Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 70. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 71. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
Table 72. Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 75. Europe Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 76. Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 77. Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 78. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 79. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
Table 80. Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 83. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 84. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 85. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 86. South America Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 87. South America Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
Table 88. South America Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 91. South America Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 92. South America Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 93. South America Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 94. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 95. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
Table 96. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Purity (2017-2022) & (Kg)
Table 99. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Purity (2023-2028) & (Kg)
Table 100. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 101. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
Table 102. Nicotinamide Mononucleotide (NMN) Raw Material
Table 103. Key Manufacturers of Nicotinamide Mononucleotide (NMN) Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Nicotinamide Mononucleotide (NMN) Typical Distributors
Table 107. Nicotinamide Mononucleotide (NMN) Typical Customers
List of Figures
Figure 1. Nicotinamide Mononucleotide (NMN) Picture
Figure 2. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Purity in 2021
Figure 3. Content Greater than or Equal to 98%
Figure 4. Content Less than 98%
Figure 5. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2021
Figure 6. Health Care Products
Figure 7. Cosmetics
Figure 8. Others
Figure 9. Global Nicotinamide Mononucleotide (NMN) Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 10. Global Nicotinamide Mononucleotide (NMN) Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Nicotinamide Mononucleotide (NMN) Sales (2017-2028) & (Kg)
Figure 12. Global Nicotinamide Mononucleotide (NMN) Price (2017-2028) & (USD/Kg)
Figure 13. Global Nicotinamide Mononucleotide (NMN) Production Capacity (2017-2028) & (Kg)
Figure 14. Global Nicotinamide Mononucleotide (NMN) Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Nicotinamide Mononucleotide (NMN) Market Drivers
Figure 16. Nicotinamide Mononucleotide (NMN) Market Restraints
Figure 17. Nicotinamide Mononucleotide (NMN) Market Trends
Figure 18. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturer in 2021
Figure 19. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturer in 2021
Figure 20. Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 24. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2028)
Figure 25. North America Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 26. Europe Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 28. South America Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (USD Million)
Figure 30. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 31. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Purity (2017-2028)
Figure 32. Global Nicotinamide Mononucleotide (NMN) Price by Purity (2017-2028) & (USD/Kg)
Figure 33. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 34. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
Figure 35. Global Nicotinamide Mononucleotide (NMN) Price by Application (2017-2028) & (USD/Kg)
Figure 36. North America Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 37. North America Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 38. North America Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2028)
Figure 39. North America Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2028)
Figure 40. United States Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 44. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 45. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2028)
Figure 46. Europe Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2028)
Figure 47. Germany Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2028)
Figure 56. China Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 63. South America Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 64. South America Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2028)
Figure 65. South America Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Purity (2017-2028)
Figure 69. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) in 2021
Figure 77. Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
Figure 78. Nicotinamide Mononucleotide (NMN) Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
jiaGou

Add To Cart

gouMai

Buy Now